At a recent social gathering, my military career came up, including the more than 100 parachute jumps I’ve done in my life. As usual, someone remarked that I must have […] The post When it comes to fight or flight, MS has made me flightless appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
Author: s3GvGjerAz
Phase 3 trial begins for at-home injectable version of Briumvi
TG Therapeutics has started enrolling participants in a Phase 3 trial to test a new version of Briumvi (ublituximab-xiiy) that can be injected at home. This change could offer greater […] The post Phase 3 trial begins for at-home injectable version of Briumvi appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
New patent covers progressive MS drug for patients in US
Immunic Therapeutics will receive a new U.S. patent covering its experimental therapy, vidofludimus calcium, and some related molecules in people with multiple sclerosis (MS). Titled “Treatment of multiple sclerosis comprising DHODH inhibitors,” […] The post New patent covers progressive MS drug for patients in US appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
ECTRIMS2025. Why could rituximab have more of an infection risk?
Tweet This week we had the suggestion that there were more infections in people treated with rituximab than oreclizumab, I suggested that there wre differences in the way that rituximab kill B cells and I also suggested that people got a third more rituximab than ocrelizumab and that it may travel round the body and…
Guest Voice: Dealing with digestive and urinary problems in MS
We all have stomach or bathroom issues from time to time. Eat the wrong thing, catch a bug, drink too much coffee, and your body will let you know. That’s […] The post Guest Voice: Dealing with digestive and urinary problems in MS appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
Reset and Focus
By Samuel Fitch When we think of the word reset, we often picture restarting a computer or a phone. Most problems on a device can be fixed with a simple restart. But when it comes to us—our physical, human selves—we don’t … Continue reading → Source: blog.mymsaa.org
Under starters orders and we are off
Tweet It was demanded that I post as many EAE and Mouse posts as possible from ECTRIMS2025… so happy to oblige. The first post from ECTRIMS2025 is about anti-CD40 ligand this blocks T cells interacting with B cells to deliver their activating signal. However a question I have posed to the students is what does…
ECTRIMS2025
Tweet Next up ….Especially for the Requester..Re-inventing a mouse model of EAE…..here we take a mouse that is is essentially empty of mouse T and B cells so we can fill it full of human cells and here they make MOG-reactive CAR-T cells and it makes lesions abit like the Transgenic MOG T cell receptor…
Ocrevus rapidly depletes B-cells, then alters T-cells in MS patients
The CD20 inhibitor Ocrevus (ocrelizumab) rapidly depletes immune B-cells in people with multiple sclerosis (MS), as expected, but ongoing treatment also leads to changes in immune T-cells, a new study […] The post Ocrevus rapidly depletes B-cells, then alters T-cells in MS patients appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
New blood test for MS receives major commercialization funding
Octave Bioscience has raised $35.6 million in funding to continue marketing its multiple sclerosis (MS) disease activity test and accelerate the development of a similar tool for Parkinson’s disease. The […] The post New blood test for MS receives major commercialization funding appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com